Literature DB >> 21161335

Effects of metabolic acidosis on expression levels of renal drug transporters.

Arong Gaowa1, Hideyuki Motohashi, Toshiya Katsura, Ken-ichi Inui.   

Abstract

PURPOSE: In the renal proximal tubular cells, various transporters play important roles in the secretion and reabsorption of drugs. When metabolic acidosis is induced, a number of adaptive changes occur in the kidney. The purpose of this study was to clarify the changes of drug transporters under the acidosis and the effects of these changes on urinary drug excretion.
METHODS: Wistar/ST rats were given 1.5% NH₄Cl in tap water for 48 h to induce the acidosis. Pharmacokinetics of PSP or metformin was evaluated. In addition, expression levels of drug transporters were examined by Western Blotting.
RESULTS: The renal clearance of PSP was markedly decreased, whereas the creatinine clearance and renal clearance of metformin were unchanged. Furthermore, Western blots indicated that the protein expression level of organic anion transporter (OAT) 3 was decreased. In contrast to OAT3 levels, OAT1 and organic cation transporter (OCT) 2 levels were unaffected. An immunohistochemical analysis showed that the OAT3 protein in the proximal tubules was localized in the basolateral membrane both of the normal and the acidosis rats.
CONCLUSION: The decrease of renal excretion of anionic drugs during metabolic acidosis might be partly due to a reduction in the level of OAT3 protein.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21161335     DOI: 10.1007/s11095-010-0348-7

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  39 in total

Review 1.  Organic anion transporters of the SLC22 family: biopharmaceutical, physiological, and pathological roles.

Authors:  Ahsan N Rizwan; Gerhard Burckhardt
Journal:  Pharm Res       Date:  2007-03       Impact factor: 4.200

Review 2.  Function and regulation of multidrug resistance proteins (MRPs) in the renal elimination of organic anions.

Authors:  Femke M van de Water; Rosalinde Masereeuw; Frans G M Russel
Journal:  Drug Metab Rev       Date:  2005       Impact factor: 4.518

3.  Gene expression levels and immunolocalization of organic ion transporters in the human kidney.

Authors:  Hideyuki Motohashi; Yuji Sakurai; Hideyuki Saito; Satohiro Masuda; Yumiko Urakami; Maki Goto; Atsushi Fukatsu; Osamu Ogawa; Ken-Ichi Inui
Journal:  J Am Soc Nephrol       Date:  2002-04       Impact factor: 10.121

Review 4.  Mechanism of increased renal gene expression during metabolic acidosis.

Authors:  N P Curthoys; G Gstraunthaler
Journal:  Am J Physiol Renal Physiol       Date:  2001-09

5.  Pharmacokinetic significance of luminal multidrug and toxin extrusion 1 in chronic renal failure rats.

Authors:  Kumiko Nishihara; Satohiro Masuda; Lin Ji; Toshiya Katsura; Ken-Ichi Inui
Journal:  Biochem Pharmacol       Date:  2007-01-09       Impact factor: 5.858

6.  Functional characteristics and membrane localization of rat multispecific organic cation transporters, OCT1 and OCT2, mediating tubular secretion of cationic drugs.

Authors:  Y Urakami; M Okuda; S Masuda; H Saito; K I Inui
Journal:  J Pharmacol Exp Ther       Date:  1998-11       Impact factor: 4.030

Review 7.  Renal response to metabolic acidosis: role of mRNA stabilization.

Authors:  H Ibrahim; Y J Lee; N P Curthoys
Journal:  Kidney Int       Date:  2007-10-03       Impact factor: 10.612

8.  Down-regulation of rat organic cation transporter rOCT2 by 5/6 nephrectomy.

Authors:  Lin Ji; Satohiro Masuda; Hideyuki Saito; Ken-ichi Inui
Journal:  Kidney Int       Date:  2002-08       Impact factor: 10.612

9.  Targeted disruption of the multidrug and toxin extrusion 1 (mate1) gene in mice reduces renal secretion of metformin.

Authors:  Masahiro Tsuda; Tomohiro Terada; Tomoyuki Mizuno; Toshiya Katsura; Jin Shimakura; Ken-ichi Inui
Journal:  Mol Pharmacol       Date:  2009-03-30       Impact factor: 4.436

10.  Expression levels of renal organic anion transporters (OATs) and their correlation with anionic drug excretion in patients with renal diseases.

Authors:  Yuji Sakurai; Hideyuki Motohashi; Harumasa Ueo; Satohiro Masuda; Hideyuki Saito; Masahiro Okuda; Noriko Mori; Motokazu Matsuura; Toshio Doi; Atsushi Fukatsu; Osamu Ogawa; Ken-ichi Inui
Journal:  Pharm Res       Date:  2004-01       Impact factor: 4.200

View more
  4 in total

Review 1.  Renal Drug Transporters and Drug Interactions.

Authors:  Anton Ivanyuk; Françoise Livio; Jérôme Biollaz; Thierry Buclin
Journal:  Clin Pharmacokinet       Date:  2017-08       Impact factor: 6.447

2.  Physiologically Based Pharmacokinetic Modelling and Prediction of Metformin Pharmacokinetics in Renal/Hepatic-Impaired Young Adults and Elderly Populations.

Authors:  Su-Jin Rhee; Hyewon Chung; SoJeong Yi; Kyung-Sang Yu; Jae-Yong Chung
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-12       Impact factor: 2.441

Review 3.  Importance of the multidrug and toxin extrusion MATE/SLC47A family to pharmacokinetics, pharmacodynamics/toxicodynamics and pharmacogenomics.

Authors:  Atsushi Yonezawa; Ken-ichi Inui
Journal:  Br J Pharmacol       Date:  2011-12       Impact factor: 8.739

4.  Construction and Functional Evaluation of a Three-Dimensional Blood-Brain Barrier Model Equipped With Human Induced Pluripotent Stem Cell-Derived Brain Microvascular Endothelial Cells.

Authors:  Toshiki Kurosawa; Daiki Sako; Yuma Tega; Yasuyuki Debori; Yumi Tomihara; Kazunobu Aoyama; Yoshiyuki Kubo; Nobuyuki Amano; Yoshiharu Deguchi
Journal:  Pharm Res       Date:  2022-04-11       Impact factor: 4.580

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.